(FIXX) – Trading Halts
-
Homology Medicines Inc. (FIXX) Announces Plan to Evaluate Strategic Options for the Company and its Genetic Medicines Programs, including HMI-103 Gene Editing Candidate for PKU
-
Homology Medicines (FIXX) Announces Encouraging Initial Data from First Dose Level in the pheEDIT Trial Evaluating Gene Editing Candidate HMI-103 in Adults with Classical PKU
-
-
Back to FIXX Stock Lookup
